KR102088696B1 - Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof - Google Patents
Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof Download PDFInfo
- Publication number
- KR102088696B1 KR102088696B1 KR1020180054661A KR20180054661A KR102088696B1 KR 102088696 B1 KR102088696 B1 KR 102088696B1 KR 1020180054661 A KR1020180054661 A KR 1020180054661A KR 20180054661 A KR20180054661 A KR 20180054661A KR 102088696 B1 KR102088696 B1 KR 102088696B1
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- alcohol
- wine
- yeast
- present
- Prior art date
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 45
- 235000021028 berry Nutrition 0.000 title claims abstract description 39
- 150000001412 amines Chemical class 0.000 title claims abstract description 33
- 230000000035 biogenic effect Effects 0.000 title claims abstract description 33
- 241000235070 Saccharomyces Species 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 80
- 102000006995 beta-Glucosidase Human genes 0.000 claims abstract description 19
- 108010047754 beta-Glucosidase Proteins 0.000 claims abstract description 19
- 235000000346 sugar Nutrition 0.000 claims abstract description 19
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 108010046334 Urease Proteins 0.000 claims abstract description 17
- 230000028327 secretion Effects 0.000 claims abstract description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 12
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 claims description 10
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 229960001340 histamine Drugs 0.000 claims description 6
- 229960003732 tyramine Drugs 0.000 claims description 5
- 239000005700 Putrescine Substances 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 68
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 68
- 235000013399 edible fruits Nutrition 0.000 abstract description 14
- 238000000855 fermentation Methods 0.000 description 21
- 230000004151 fermentation Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 17
- 239000002609 medium Substances 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 235000021107 fermented food Nutrition 0.000 description 11
- 244000005700 microbiome Species 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 9
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 9
- 235000021014 blueberries Nutrition 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 240000000851 Vaccinium corymbosum Species 0.000 description 8
- 239000007789 gas Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 108020004463 18S ribosomal RNA Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- -1 wine Chemical compound 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 235000019990 fruit wine Nutrition 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 229930182836 (R)-noradrenaline Natural products 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000120652 Cellulomonas sp. Species 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 244000111447 Rubus phoenicolasius Species 0.000 description 1
- 235000003963 Rubus phoenicolasius Nutrition 0.000 description 1
- 241000187420 Streptomyces reticuli Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000019899 phobic disease Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- AUALKMYBYGCYNY-UHFFFAOYSA-E triazanium;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+) Chemical compound [NH4+].[NH4+].[NH4+].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O AUALKMYBYGCYNY-UHFFFAOYSA-E 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G1/00—Preparation of wine or sparkling wine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/02—Preparation of other alcoholic beverages by fermentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/76—Yeasts
- A23V2250/762—Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G2200/00—Special features
- C12G2200/05—Use of particular microorganisms in the preparation of wine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G2200/00—Special features
- C12G2200/11—Use of genetically modified microorganisms in the preparation of wine
-
- C12R1/865—
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Abstract
본 발명은 베리류 와인 제조를 위한 바이오제닉 아민 비생성 사카로마이세스 세레비지애 BA34 균주 및 이의 용도에 관한 것으로, 본 발명에서는 베리류 과실로부터 분리된 사카로마이세스 세레비지애(Saccharomyces cerevisiae) BA34 균주가 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 것을 확인하였다. 따라서, 본 발명의 사카로마이세스 세레비지애 BA34 균주를 이용하여 바이오제닉 아민이 없는 안전한 와인을 제공할 수 있으므로, 산업적으로 유용하게 이용될 수 있을 것으로 기대된다.The present invention relates to a non-producing Saccharomyces cerevisiae BA34 strain and its use for the production of berry wines, in the present invention, Saccharomyces cerevisiae isolated from berry fruits cerevisiae ) It was confirmed that the BA34 strain is resistant to alcohol, sugar, and sulfurous acid, has alcohol-producing ability, and β-glucosidase secretion ability, and does not produce biogenic amines and ureases. Therefore, it is expected that the Saccharomyces cerevisiae BA34 strain of the present invention can provide a safe wine free of biogenic amines, and thus can be usefully used industrially.
Description
본 발명은 베리류 와인 제조를 위한 바이오제닉 아민 비생성 사카로마이세스 세레비지애 BA34 균주 및 이의 용도에 관한 것이다.The present invention relates to a non-producing Saccharomyces cerevisiae BA34 strain and its use for the production of berry wines.
우리나라는 고대로부터 식품의 제조에 사용되는 발효기술과 숙성기술이 발달해 왔고, 이에 따라 발효기술을 이용한 전통주도 지속적으로 개발되고 있다. 전통주는 제조방법에 따라 크게 전통 증류주와 전통 발효주로 나누어지며, 특히 전통 발효주는 첨가된 재료에 따라 맛과 향이 독특하고 각기 개성적인 기능성을 함유하고 있다.In Korea, fermentation technology and aging technology used in the manufacture of food have been developed since ancient times, and accordingly, traditional alcoholic beverages using fermentation technology have been continuously developed. Traditional liquors are largely divided into traditional distilled liquor and traditional fermented liquor according to the manufacturing method. In particular, traditional fermented liquor has a unique taste and aroma according to the added ingredients, and each has unique functionality.
전통주의 발효에는 사카로마이세스(Saccharomyces) 속, 아스퍼질러스(Aspergillus) 속, 바실러스(Bacillus) 속, 락토바실러스(Lactobacillus) 속 등의 균주들이 사용되고 있는데, 최근에는 발효 재료와 더불어 이와 같은 발효 균주들이 발효과정 중에 생산하는 부산물의 효능 및 특성을 강조한 건강 기능성 발효주가 생산되고 있다.There fermentation of traditionalism include saccharide as MY access (Saccharomyces) genus Aspergillus (Aspergillus) genus Bacillus (Bacillus) genus Lactobacillus bacteria (Lactobacillus) in such strains have been used, in recent years, with fermented material such fermentation strain Health functional fermented liquor is being produced which emphasizes the efficacy and characteristics of byproducts produced during the fermentation process.
발효과정에서 발효 미생물들에 의해 생산되는 것 중 하나인 감마-아미노뷰티르산(γ-amino butyric acid, GABA)은 자연계에 분포하는 비단백질성 아미노산의 일종으로 뇌나 척수와 같은 중추신경계의 주된 억제성 신경전달물질(inhibitory neurotransmitter)로 알려져 있다. 뇌의 혈류를 활발하게 하고 뇌에 산소 공급량을 증가시켜 뇌세포의 대사기능을 촉진시키며, 혈액 내의 중성지방을 줄이고 간기능을 개선시키는 등의 여러 약리 활성으로 인해, 뇌동맥 휴유증에 의한 두통, 귀 울림, 의욕저하 등의 치료제에 응용되어 왔다. 또한, 고혈압과 같은 성인병 등의 예방 및 개선에 효과적인 것으로 밝혀져, 기능성 식품소재로서의 관심이 고조되고 있고 최근에는 감마-아미노뷰티르산을 다량 함유하는 음료가 출시되기도 했다.Gamma-amino butyric acid (GABA), one of the products produced by fermentation microorganisms during fermentation, is a non-proteinaceous amino acid that is distributed in nature and mainly inhibits the central nervous system, such as the brain or spinal cord. It is known as an inhibitory neurotransmitter. Due to various pharmacological activities such as activating the blood flow of the brain and increasing the oxygen supply to the brain to promote the metabolic function of brain cells, reducing triglycerides in the blood and improving liver function, headaches and ringing caused by cerebral arterial idleness , It has been applied to therapeutic agents such as decreased motivation. In addition, it has been found to be effective in the prevention and improvement of adult diseases such as hypertension, increasing interest as a functional food material, and recently, beverages containing a large amount of gamma-aminobutyric acid have been released.
한편, 바이오제닉 아민(biogenic amine, BA)은 인체에서 성장조절 및 염증조절, 신경전달 등의 생리적 기능을 담당하지만, 인체의 분해 한도를 넘어서는 바이오제닉 아민을 식품을 통해서 섭취하는 경우에는 유해한 증상이 나타난다. 따라서 발효에 있어서, 발효과정 동안 바이오제닉 아민을 생산하지 않는 발효 균주의 선발이 매우 중요하다.On the other hand, biogenic amine (biogenic amine, BA) is responsible for physiological functions such as growth control, inflammation control, and neurotransmission in the human body, but when the biogenic amine exceeding the decomposition limit of the human body is consumed through food, there are harmful symptoms. appear. Therefore, in fermentation, it is very important to select a fermentation strain that does not produce biogenic amine during the fermentation process.
와인과 같은 베리류의 알코올 발효에는 다양한 미생물들이 관여하고 있으며 복잡한 화학적 단계를 반복하면서 미생물들 간 다양한 작용을 통해 이루어진다. 많은 해외 국가에서는 와인의 제조를 위하여 사카로마이세스 세레비지애를 스타터 균주로 사용하여 와인의 품질 향상을 도모하고 있으며, 알코올 발효능이 우수하고 와인 제조 시 품질 향상에 도움이 되는 효모의 선별에 많은 노력을 기울이고 있다.A variety of microorganisms are involved in the fermentation of berry-like alcohol, such as wine, and are made through various actions between microorganisms while repeating complex chemical steps. Many overseas countries use Saccharomyces cerevisiae as a starter strain for the production of wine to improve the quality of wine, and for the selection of yeast that has excellent alcohol fermentation ability and helps to improve the quality of wine production. There is a lot of effort.
한편, 한국등록특허 제1599271호에서는 '베리류 과실로부터 분리된 알코올을 생산하고 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 BA42 균주 및 이의 용도'가 개시되어 있고, 한국등록특허 제1599270호에서는 '오디로부터 분리된 알코올을 생산하고 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 BA33 균주 및 이의 용도'가 개시되어 있으나, 본 발명에서와 같이, '베리류 와인 제조를 위한 바이오제닉 아민 비생성 사카로마이세스 세레비지애 BA34 균주 및 이의 용도'에 대해서는 밝혀진 바가 전혀 없다.On the other hand, Korean Registered Patent No.1599271 discloses 'Saccharomyces cerevisiae BA42 strain that produces alcohol separated from berry fruits and does not produce biogenic amines and uses thereof', and Korean Registered Patent No. 1599270 In 'Saccharomyces cerevisiae BA33 strain that produces alcohol separated from Audi and does not produce biogenic amine and its use' is disclosed, as in the present invention, 'Biogenic amine for berry wine production No non-producing Saccharomyces cerevisiae BA34 strain and uses thereof have been found.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 베리류 과실로부터 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisiae) BA34 균주를 분리하였다.The present invention has been derived by the above-mentioned demands, in the present invention, it is resistant to alcohol, sugar, and sulfurous acid from berry fruits, has alcohol-producing ability, and β-glucosidase secretion ability, and biogenic amine. And Saccharomyces cerevisiae that does not produce urease (Saccharomyces cerevisiae) BA34 strain was isolated.
따라서, 본 발명의 사카로마이세스 세레비지애 BA34 균주는 와인 제조를 위한 스타터 균주 등 발효식품 관련 산업에 다양하게 사용이 가능함을 확인함으로써, 본 발명을 완성하였다.Accordingly, the present invention was completed by confirming that the Saccharomyces cerevisiae BA34 strain of the present invention can be variously used in fermented food related industries such as starter strains for wine production.
상기 과제를 해결하기 위해, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisae) BA34 균주(KCCM12243P)를 제공한다.In order to solve the above problems, the present invention is resistant to alcohol, sugar and sulfurous acid, has alcohol-producing ability and β-glucosidase secretion ability, and does not produce biogenic amines and ureases. Saccharomyces cerevisae BA34 strain (KCCM12243P) is provided.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다.In addition, the present invention provides a composition for producing alcohol containing the strain, a culture solution thereof, a concentrate solution of the culture solution, or a dried product thereof as an active ingredient.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다.In addition, the present invention provides a starter composition for preparing fermented food comprising the strain, a culture solution thereof, a concentrate solution of the culture solution, or a dried product thereof as an active ingredient.
본 발명에서는 베리류 과실로부터 분리된 사카로마이세스 세레비지애(Saccharomyces cerevisiae) BA34 균주가 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 것을 확인하였다. 따라서, 본 발명의 사카로마이세스 세레비지애 BA34 균주를 이용하여 바이오제닉 아민이 없는 안전한 와인을 제공할 수 있으므로, 산업적으로 유용하게 이용될 수 있을 것으로 기대된다.In the present invention, the Saccharomyces cerevisiae BA34 strain isolated from berry fruits is resistant to alcohol, sugars and sulfites, has alcohol production capacity and β-glucosidase secretion ability, It was confirmed that no biogenic amine and urease were produced. Therefore, it is expected that the Saccharomyces cerevisiae BA34 strain of the present invention can provide a safe wine free of biogenic amines, and thus can be usefully used industrially.
도 1은 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) BA34 균주(KCCM12243P)의 18S rRNA 유전자 기초의 계통도를 나타낸다.
도 2는 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) BA34 균주(KCCM12243P)의 에탄올, 당 및 아황산의 상이한 농도에 대한 내성을 분석한 결과이다. 상이한 농도의 에탄올, 당 및 아황산를 포함하는 YPD 배지에서 30℃, 200 rpm, 35hr 배양 후 건조 세포 중량(g/ℓ)으로 사카로마이세스 세레비지애의 저항성을 나타내었다. (A) 상이한 에탄올 농도(0%, 8%, 14%, 및 20%)에 대한 사카로마이세스 세레비지애 저항성, (B) 상이한 글루코스 농도(3%, 30%, 40%, 및 50%)에 대한 사카로마이세스 세레비지애 저항성, (C) 상이한 아황산 농도(0 ppm, 100 ppm, 200 ppm, 및 300 ppm)에 대한 사카로마이세스 세레비지애 저항성. 실험을 3 반복구로 수행한 평균값이다.Figure 1 shows a schematic diagram of the 18S rRNA gene base of Saccharomyces cerevisae BA34 strain (KCCM12243P) isolated from the present invention.
Figure 2 is a result of analyzing the resistance to different concentrations of ethanol, sugar and sulfurous acid of the Saccharomyces cerevisae BA34 strain (KCCM12243P) isolated from the present invention. After incubation at 30 ° C, 200 rpm, and 35 hr in YPD medium containing different concentrations of ethanol, sugar, and sulfurous acid, resistance of Saccharomyces cerevisiae was exhibited by dry cell weight (g / L). (A) Saccharomyces cerevisiae resistance to different ethanol concentrations (0%, 8%, 14%, and 20%), (B) Different glucose concentrations (3%, 30%, 40%, and 50%) Saccharomyces cerevisiae resistance to), (C) Saccharomyces cerevisiae resistance to different sulfite concentrations (0 ppm, 100 ppm, 200 ppm, and 300 ppm). This is the average value of the experiments performed with 3 replicates.
본 발명의 목적을 달성하기 위하여, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisae) BA34 균주(KCCM12243P)를 제공한다.In order to achieve the object of the present invention, the present invention is resistant to alcohol, sugar and sulfurous acid, has alcohol-producing ability and β-glucosidase secretion ability, and does not produce biogenic amines and ureases. Provided is the Saccharomyces cerevisae BA34 strain (KCCM12243P).
본 발명에 따른 사카로마이세스 세레비지애 BA34 균주는 전라북도 순창군에서 재배 및 수확한 오디, 머루, 복분자, 블루베리와 같은 각종 베리류 과실 및 엑기스로부터 분리된 균주들 중에서 알코올을 생산하고 오디 와인, 복분자 와인 및 블루베리 와인을 제조하였을 때 바이오제닉 아민을 생산하지 않으며, 알코올, 당 및 아황산에 대한 내성이 있으므로 베리류 와인 제조용 발효 균주로서 가장 적합한 균주로 선발된 것이다.Saccharomyces cerevisiae BA34 strain according to the present invention produces alcohol from strains separated from various berry fruits and extracts such as Audi, Murru, Bokbunja, Blueberry grown and harvested in Sunchang-gun, Jeollabuk-do, Audi wine, Bokbunja When producing wine and blueberry wine, it does not produce biogenic amine, and is resistant to alcohol, sugar, and sulfurous acid, so it is selected as the most suitable strain as a fermentation strain for berry wine production.
상기 선발된 본 발명의 BA34 균주는 18S rRNA 영역의 염기서열 분석을 실시한 결과, 사카로마이세스 세레비지애(Saccharomyces cerevisiae)로 동정되었다.As a result of sequencing of the 18S rRNA region of the selected BA34 strain of the present invention, Saccharomyces cerevisiae cerevisiae ).
본 발명의 균주 사카로마이세스 세레비지애 BA34 균주를 한국미생물보존센터에 2018년 3월 28일자로 기탁하였다(기탁번호: KCCM12243P).The strain Saccharomyces cerevisiae BA34 of the present invention was deposited with the Korea Microbial Conservation Center on March 28, 2018 (Accession No .: KCCM12243P).
본 발명의 일 구현 예에 따른 균주에서, 상기 바이오제닉 아민은 히스타민(histamine), 퓨트레신(putrescine), 카다베린(cadaverine), 스퍼미딘(spermidine), 스퍼민(spermine), 트립타민(tryptamine), 히세아민(hiseamine), 2-페닐에틸아민(2-phenylethylamine), 티라민(tyramine), 세로토닌(serotonin), L-노르에피네프린(L-norepinephrine) 또는 도파민(dopamine)일 수 있고, 바람직하게는 히스타민, 티라민, 퓨트레신 또는 카다베린일 수 있으나, 이에 제한되지 않는다.In a strain according to an embodiment of the present invention, the biogenic amine is histamine, putrescine, cadaverine, spermidine, spermine, tryptamine , Hisiseamine, 2-phenylethylamine, tyramine, serotonin, L-norepinephrine or dopamine, preferably histamine , Tyramine, putrescine or cadaverine, but is not limited thereto.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다.In addition, the present invention provides a composition for producing alcohol containing the strain or a culture medium thereof as an active ingredient.
본 발명의 일 구현 예에 따른 조성물에서, 상기 알코올은 곡류 또는 과실류를 발효시킨 알코올일 수 있으며, 가장 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다.In the composition according to an embodiment of the present invention, the alcohol may be alcohol fermented grains or fruits, most preferably wine fermented berries, but is not limited thereto.
본 발명의 균주를 배양하는 방법은 당업계에 통상적으로 이용되는 방법에 따라 배양할 수 있으며, 특별한 방법에 한정되는 것은 아니다.The method for culturing the strain of the present invention may be cultured according to a method commonly used in the art, and is not limited to a special method.
본 발명의 균주를 배양하는 단계에서 얻어지는 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 첨가제로 사용할 경우, 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 그대로 첨가하거나 다른 첨가제를 함께 사용할 수 있으며, 통상적인 방법에 따라 적절하게 사용될 수 있다 유효 성분의 혼합양은 그의 사용 목적에 따라 적합하게 결정될 수 있다.When using the concentrate obtained from the step of culturing the strain of the present invention or the culture of the strain or the concentrate of the culture medium of the strain as an additive, the culture medium of the strain or the strain or the culture medium of the strain is added as it is, or Other additives may be used together, and may be suitably used according to conventional methods. The mixing amount of the active ingredients may be appropriately determined according to the purpose of use.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다.In addition, the present invention provides a starter composition for preparing fermented food comprising the strain, a culture solution thereof, a concentrate solution of the culture solution, or a dried product thereof as an active ingredient.
본 발명에 있어서, 발효식품 제조용 스타터(starter)란 발효식품 제조를 위해 발효에 관여하는 미생물을 포함하는 제제 또는 조성물을 의미한다. 발효식품 제조 시에 첨가함으로써 발효된 식품에서 생장할 수 있는 미생물 또는 우점종으로 생장할 수 있는 미생물을 제공하기 위하여 사용된다. 상기 식품 발효용 스타터를 사용하여 식품을 제조하는 경우, 상기 식품 발효용 스타터에 포함된 미생물에 의하여, 식품의 품질을 일정하게 조절하거나, 특정한 목적, 일 예로 식품에서 이취를 발생시키지 않거나, 감소시키는 목적을 달성할 수 있다. 본 발명에서는 사카로마이세스 세레비지애 BA34 균주 또는 이의 배양액을 스타터 균주로 이용함으로써, 알코올 및 β-글루코시다제(β-glucosidase)가 생성되고, 바이오제닉 아민 및 우레아제를 생성되지 않는 발효 식품을 제조할 수 있다. In the present invention, a starter for preparing fermented food means a preparation or composition containing microorganisms involved in fermentation for the production of fermented food. It is used to provide microorganisms that can grow as a dominant species or microorganisms that can grow in fermented foods by adding them during the production of fermented foods. When the food is prepared using the food fermentation starter, the quality of the food is constantly controlled by the microorganisms contained in the food fermentation starter, or a specific purpose, for example, does not cause or reduce odor in food. You can achieve your purpose. In the present invention, by using the Saccharomyces cerevisiae BA34 strain or a culture medium thereof as a starter strain, alcohol and β-glucosidase (β-glucosidase) are produced, and a fermented food that does not produce biogenic amine and urease Can be produced.
본 발명의 일 구현 예에 따른 발효식품 제조용 스타터 조성물에서, 상기 발효식품은 곡류 또는 과실류를 발효시킨 발효주, 베리류를 발효시킨 와인, 김치, 장류 또는 발효유 등일 수 있고, 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다.In the starter composition for preparing fermented food according to one embodiment of the present invention, the fermented food may be fermented wine fermented with grains or fruits, wine fermented with berry, kimchi, jang or fermented milk, preferably wine fermented with berry It may be, but is not limited thereto.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are merely illustrative of the present invention, and the contents of the present invention are not limited to the following examples.
재료 및 방법Materials and methods
효모 분리 및 배양조건Yeast separation and culture conditions
다양한 효모를 분리하기 위해 전라북도 순창군에서 재배 및 수확한 오디, 머루, 복분자, 블루베리와 같은 각종 베리류 과실 및 엑기스를 구매 사용하였다. 10g의 베리류 과실 및 액기스를 균질화시킨 다음 100㎖의 멸균생리식염수에 넣어 십진법으로 희석하였고, 박테리아 생장을 억제하기 위해 100 ㎍/㎖의 클로람페니콜을 함유한 YPD(효모추출물 1%, 펩톤 2%, 포도당 3%) 고체배지에 도말하여 30℃에서 2일간 배양하였다. 순수한 효모 콜로니를 분리하기 위해, 단일 콜로니를 분리하였고, YPD 액체배지에서 30℃에서 2일간 배양하였다. 효모 균주 중 베리류 와인 발효에 적합한 바이오제닉 아민 비생성 효모를 선별하였고, 20%의 글리세롤을 포함한 YPD 액체배지에 혼합하여 4℃에서 보관하였다. 세포의 활성화는 YPD 액체배지에서 30℃, 2일간 배양하여 활성화하여 사용하였다.In order to separate various yeasts, various berry fruits and extracts such as audi, fruit, bokbunja, and blueberries grown and harvested in Sunchang-gun, Jeollabuk-do were purchased and used. After homogenizing 10 g of berry fruits and extracts, diluting them in decimal with 100 ml of sterile physiological saline, YPD (100%
알코올 발효성 효모의 분리Separation of alcoholic fermentable yeast
가스 생성능은 듀람 시험을 통하여 확인하였다. 선별된 균주의 배양을 위해 효모는 YPD 액체배지에서 30℃, 24시간 동안 교반하여 배양하였다. 배양액의 2%는 20%의 포도당을 함유한 5㎖의 YPD 액체배지를 함유한 듀람관에 접종하였다. 이후 교반 없이 30℃에서 모든 듀람 시험관은 48시간 동안 배양하고, 48시간 후 가스 생성여부를 확인하여 1차 선별하였고 1차 선별 효모들을 20% 포도당이 함유된 YPD에 접종하여 48시간 배양후 배양액을 원심분리하여 배양 상등액을 취해 0.45μm 시린지 필터를 이용하여 필터한 뒤 표 1에 따른 조건에 따라 HPLC를 이용해 알코올 생성능을 분석하였다. The gas generating ability was confirmed through the Durham test. For cultivation of the selected strains, yeast was cultured by stirring in YPD liquid medium at 30 ° C. for 24 hours. 2% of the culture was inoculated into a Duram tube containing 5 ml of YPD liquid medium containing 20% glucose. After that, all the Duram test tubes were incubated for 48 hours at 30 ° C without agitation, and after 48 hours, the gas was first checked by checking whether gas was generated, and the primary selection yeasts were inoculated in YPD containing 20% glucose, and the culture solution was cultured after 48 hours of incubation After centrifugation, the culture supernatant was taken and filtered using a 0.45 μm syringe filter, and then alcohol generation ability was analyzed using HPLC according to the conditions according to Table 1.
(Agilent Technologies, Santa Clara, CA, USA)Agilent 1200 series
(Agilent Technologies, Santa Clara, CA, USA)
(Agilent Technologies, Santa Clara, CA, USA)Agilent 1200 series
(Agilent Technologies, Santa Clara, CA, USA)
(Bio-Rad, Hercules, CA, USA) Aminex HPX 87H column, 300 Х 7.8 mm
(Bio-Rad, Hercules, CA, USA)
바이오제닉Biogenic 아민Amine 생성 여부 확인 Check creation
선별 분리주의 바이오제닉 아민 생성 여부 조사는 YPD 액체배지에 각 분리주를 접종한 후 30℃ 쉐이킹 인큐베이터 150 rpm에서 24시간 전배양 후 배양액 1 ㎖을 티라민, 히스타민, 퓨트레이신, 카다베린의 전구체 아미노산인 티로신, 히스티딘, 아르기닌, 리신이 0.1% 포함된 YPD 액체배지 9㎖에 접종하고 30℃ 쉐이킹 인큐베이터 150rpm에서 48시간 동안 본배양하였다. 본배양액은 13,000rpm에서 30분간 원심분리하여 균체를 제거하고, 균체가 제거된 배양 상등액과 베리류를 이용해 제조한 와인을 바이오제닉 아민 분석을 위한 시료로 사용하였다. 시료 용액과 표준 용액을 각각 0.5 ㎖ 취한 후 0.25 ㎖ 1,7-디아미노헵탄(Sigma-aldrich) 및 0.25 ㎖ 포화 Na2CO3 용액(Sigma-aldrich), 1% 아세톤 (Sigma-aldrich), 0.4 ㎖ 단실 클로라이드(Sigma-aldrich)을 혼합한 후 45℃에서 1시간 동안 유도체화하였다. 유도체화 한 시료에 0.25 ㎖의 10% 프롤린(Sigma-aldrich)을 가한 후 잔량의 단실 클로라이드를 제거한 뒤 2.5 ㎖의 에틸에테르 (Samchun, Seoul, Korea)를 가하여 3분간 진탕한 후, 분리된 상등액을 취하여 증발시키고 남은 잔사를 0.5 ㎖ 아세토니트릴에 정용하여 0.45 ㎛ 시린지 필터 (Sartorius)로 여과하여 분석에 사용하였다. 바이오제닉 아민 분석을 위한 기기 분석 조건은 표 1과 같다.Investigation as to whether or not to generate biogenic amines of the selective isolates, after inoculating each isolate into the YPD liquid medium, and pre-incubating for 24 hours at 150 rpm in a shaking incubator at 30 ° C, 1 ml of the culture medium is a precursor amino acid of tyramine, histamine, putresin, and cadaverine. Tyrosine, histidine, arginine, and lysine were inoculated into 9 ml of a YPD liquid medium containing 0.1% and incubated for 48 hours in a 30 ° C shaking incubator 150 rpm. The culture medium was centrifuged at 13,000 rpm for 30 minutes to remove the cells, and the wine produced using the culture supernatant and berries from which the cells were removed was used as a sample for biogenic amine analysis. 0.5 ml of sample solution and standard solution were respectively taken, and then 0.25
우레아제 Urease 생성여부확인Confirmation of creation
유해효소인 우레아제(urease)의 생성여부는 우레아 신속 테스트 키트(MB cell, Korea)를 이용하여 확인하였다. 우레아 신속 테스트 키트에 선별 균주를 접종하고 바세린 오일(vaseline oil)을 첨가하여 산소가 차단된 상태로 37℃에서 24시간동안 배양하였고 4시간 간격으로 색변화를 관찰하여 우레아제 생성여부를 확인하였다. The generation of the urease, a harmful enzyme, was confirmed using a urea rapid test kit (MB cell, Korea). The urea rapid test kit was inoculated with the selected strain, and petroleum was added to it, and petroleum was incubated at 37 ° C. for 24 hours in a state where oxygen was blocked, and color change was observed at intervals of 4 hours to confirm whether urease was produced.
β-β- 글루코시다제Glucosidase 효소활성 Enzyme activity
β-글루코시다제(β-glucosidase) 효소활성을 분석하기 위해 1.0% 에스쿨린(esculin)과 0.5% 페릭 암모늄 시트레이트(ferric ammonium citrate)를 첨가하여 제조한 락토바실리 MRS 아가 플레이트에 분리주를 접종하여 37℃에서 24시간 배양한 후 콜로니 주변에 생기는 검정색 투명환의 유무에 따라 β-글루코시다제 효소활성을 조사하였다. To analyze β-glucosidase enzyme activity, lactobacilli MRS agar plates prepared by adding 1.0% esculin and 0.5% ferric ammonium citrate were inoculated with isolates. After incubation at 37 ° C for 24 hours, β-glucosidase enzyme activity was investigated depending on the presence or absence of a black transparent ring formed around the colony.
효모의 동정 및 계통수 작성Identification of yeast and creation of phylogenetic tree
최종적으로 선별 균주 중에서 베리류 와인 발효에 적합한 효모 BA34를 선별하였으며, 선별 균주를 동정하기 위해 DNA를 추출하여 18S rRNA 유전자를 분석하여 Cosmogene tech.에 의뢰하여 동정하였다. 염기서열은 ExTaxone-e 서버(http://www.eztaxon.org)를 통해 표준 균주의 염기서열을 확보하여 MEGA 6.0 프로그램을 사용하여 염기서열간 상호 비교 후 계통도를 작성하였다. 계통도는 Neighbor-joining 알고리즘을 사용하였으며, 1,000회 반복으로 부트스트랩(bootstrapping)하여 작성한 계통도의 견고성을 확인하였다. Finally, yeast BA34 suitable for fermentation of berry wine was selected from the selected strains, and DNAs were extracted to identify the selected strains, and the 18S rRNA gene was analyzed and requested by Cosmogene tech. The nucleotide sequence was obtained through the ExTaxone-e server ( http://www.eztaxon.org ), and the nucleotide sequence of the standard strain was obtained, and the MEGA 6.0 program was used to compare the nucleotide sequences to create a systematic diagram. Neighbor-joining algorithm was used for the tree diagram, and the robustness of the tree diagram created by bootstrapping at 1,000 iterations was confirmed.
알코올 내성, Alcohol resistant, 당내성Sugar resistance , 아황산 내성 조사, Sulfite resistance investigation
사카로마이세스 세레비지애 BA34의 알코올 내성을 조사하기 위하여 0, 8, 14, 20%의 무수에탄올을 YPD 액체배지에 효모를 접종한 후 바로 첨가하였다. 건조 균체량은 30℃에서 72시간동안 배양하여 조사하였다. 당내성은 3, 30, 40, 50%의 포도당을 함유한 YPD 액체배지에 30℃에서 48시간 동안 효모를 배양한 후 건조 균체량을 측정하여 조사하였다. 아황산 내성은 100, 200, 300 ppm의 메타중아황산칼륨을 첨가한 YPD 액체배지에서 30℃에서 48시간동안 배양하여 건조 균체량을 측정하였다.To investigate the alcohol resistance of Saccharomyces cerevisiae BA34, 0, 8, 14, and 20% anhydrous ethanol were added immediately after inoculating yeast into the YPD liquid medium. Dry cell mass was investigated by incubation at 30 ° C for 72 hours. Glucose tolerance was investigated by incubating yeast in a YPD liquid medium containing 3, 30, 40, and 50% glucose at 30 ° C. for 48 hours and measuring the amount of dry cells. The sulfurous acid resistance was measured by incubating for 48 hours at 30 ° C in a YPD liquid medium to which potassium metabisulfite of 100, 200 and 300 ppm was added to measure the amount of dry cells.
베리류를Berries 이용한 Used 와인wine 제조 Produce
베리를 와인을 제조하기 위해 YPD 액체배지에 선별한 효모를 접종하여 30℃ 쉐이킹 인큐베이터에서 150rpm, 24시간 배양하였고, 배양액은 13,000rpm에서 20분간 원심분리 하였다. 분리된 균체를 멸균 증류수에 3회 세척하여 베리류 와인 제조를 위한 스타터로 사용하였다. 베리류 발효액은 오디, 복분자, 블루베리 과실을 각각 분쇄하여 여과지로 여과한 원액에 백설탕을 첨가하여 당도를 12°Brix가 되도록 조정한 후 살균한 것을 사용하였다. 이에 앞서 배양한 효모 2%(v/v)를 접종하고 30℃ 쉐이킹 인큐베이터에서 150rpm으로 48시간 동안 진탕 배양한 발효액을 주모로 사용하였다. 베리류 와인의 제조는 백설탕을 첨가하여 22°Brix로 조정한 후 멸균한 과실액에 주모를 2%(v/v) 접종한 다음 25~30℃에서 5일간 발효하고, 7일간 숙성기간을 거쳐 제조하였다.Berry was inoculated with yeast selected from YPD liquid medium to produce wine, and cultured at 150 rpm in a 30 ° C shaking incubator for 24 hours, and the culture was centrifuged at 13,000 rpm for 20 minutes. The separated cells were washed three times in sterile distilled water and used as a starter for berry wine production. The berry fermentation broth was used by sterilizing the sugar content to 12 ° Brix by adding white sugar to the stock solution filtered through filter paper by pulverizing Audi, bokbunja, and blueberry fruits, respectively. Prior to this, 2% (v / v) of the cultured yeast was inoculated, and a fermentation broth cultured with shaking at 150 rpm in a 30 ° C shaking incubator for 48 hours was used as a mother. The production of berry wine is adjusted to 22 ° Brix by adding white sugar, and then inoculated with 2% (v / v) of the mother in sterile fruit juice, fermented for 5 days at 25 ~ 30 ℃, and aged through a 7-day aging period. Did.
실시예Example 1. One. 베리류Berries 과실로부터 효모의 분리 Separation of yeast from fruit
본 발명에서는 효모 균주의 분리를 위하여 베리류 과실 및 엑기스로부터 효모 분리주를 선별하였고, 선별 분리주는 다음 연구의 진행을 위해 -20℃에 보관한 뒤 다음 연구에 이용하였다. In the present invention, yeast isolates were selected from berry fruits and extracts for separation of yeast strains, and the isolates were stored at -20 ° C for the next study and used in the next study.
실시예Example 2. 가스 및 알코올 2. Gas and alcohol 생성능을Generating ability 갖는 효모의 선별 Selection of yeast to have
선별 분리주를 대상으로 실험을 진행하였으며, 듀람 시험관에서의 가스 형성은 30℃ 정치 배양기에서 48시간 동안 배양한 후 관찰하였다. 모든 배양 상등액을 이용하여 가스 형성 여부를 조사하였고, 가스를 형성하는 균주를 1차로 선별하였다. 그러나 보고에 따르면 대부분의 효모들은 식별 가능한 가스 형성능 없이도 알코올을 생성하는 역할을 수행하기 때문에 추가적으로 HPLC 분석을 통하여 알코올 생성 여부를 조사하였고, 그 결과 최종적으로 5% 이상의 알코올 생성능을 갖는 7개의 효모를 2차 선별하였다(표 2).The experiment was conducted on the selective isolates, and gas formation in the Duram test tube was observed after incubation for 48 hours in a 30 ° C stationary incubator. Gas formation was investigated using all culture supernatant, and strains forming gas were first selected. However, according to the report, since most yeasts play a role of producing alcohol without an identifiable gas-forming ability, additionally, HPLC analysis was conducted to determine whether alcohols were produced, and as a result, 7 yeasts having an alcohol generating ability of 5% or more were finally obtained. Tea was selected (Table 2).
실시예Example 3. 3. 바이오제닉Biogenic 아민Amine 비생성Non-generation 효모의 선별 Yeast screening
앞서 1차로 선별한 효모를 대상으로 바이오제닉 아민 전구체가 포함된 액체배지에서 바이오제닉 아민 생성여부를 조사하였고, 2차로 베리류를 이용해 와인을 제조한 후 히스타민, 티라민, 퓨트레신과 카다베린 함량을 조사하였다. 대조구로는 앞서 알려진 바와 같이 베리류 과실 자체에 존재하는 바이오제닉 아민의 검출 가능성을 고려하여 베리류의 착즙액을 사용하였고, 베리류 와인을 제조하여 선별 효모에 의한 바이오닉아민의 생성여부를 확인하였다. 결과는 Vasantha Rupasinghe와 Clegg의 결과와 동일하게 과실 자체에도 히스타민이 존재하고 있음을 확인하였고, 결과는 표 3와 같으며, 베리류 착즙액 자체에서 뿐만 아니라 일부 균주에 의해 바이오제닉 아민이이 검출되었으나 대부분 정량되지 않거나 미비한 수치를 나타내었고, BA34의 경우 베리류를 이용해 제조한 와인에서 4종의 바이오제닉 아민이 모두 검출되지 않았으므로 베리류를 이용한 와인 제조에 적합한 균주로 선정하였다.For the yeast that was selected as the first step, it was investigated whether or not biogenic amine was produced in the liquid medium containing the biogenic amine precursor, and secondly, after making wine using berries, the contents of histamine, tyramine, putrescine and cadaverine were investigated. Did. As a control, a juice solution of berries was used in consideration of the possibility of detection of biogenic amine present in the berries of itself, and berry wine was prepared to confirm whether or not to produce bionic amines by selective yeast. As a result of Vasantha Rupasinghe and Clegg, it was confirmed that histamine was also present in the fruit itself, and the results are shown in Table 3.Biogenic amine was detected by some strains as well as in the berry juice itself, but mostly quantitative In the case of BA34, since all four biogenic amines were not detected in wines produced using berries, BA34 was selected as a suitable strain for wine production using berries.
결과는 3번 측정하였으며 표준편차로 표기하였음Results were measured 3 times and indicated as standard deviation
a 대조구로써 착즙액 자체 또는 전구체만 들어있는 YPD 액체배지 a YPD liquid medium containing only the juice itself or the precursor as a control
b N.D. - 검출되지 않음 b ND-not detected
c N.Q. - 정량되지 않음 c NQ-not quantified
실시예Example 4. 4. 베리류Berries 와인의Wine 알코올 함량 분석 Alcohol content analysis
사카로마이세스 세레비지애로 동정된 BBA03, BBA19, BBA23, BA34, BBA46, BBA88, BBA91의 7개의 균주를 이용하여 베리류 와인을 제조해 알코올 함량을 분석한 결과는 표 4와 같다. 오디 및 블루베리, 복분자 원액에 균주를 접종하지 않은 대조구에서는 에탄올 검출이 되지 않았으며, 오디 와인의 경우 대조구로 접종한 시판효모(곡주)가 18.82%로 가장 높게 나타났고, 선별 균주 중에서는 BBA23 균주를 접종하여 제조한 와인에서 알코올 함량 17.01%로 가장 높게 나타났다. 블루베리 와인에서는 대조구로 접종한 시판효모 2종보다 선별한 BBA03을 제외한 6종의 균주가 더 높게 나타났다. 복분자 와인의 경우 BA34이 18.68%로 대조구를 포함한 선별균주 중 가장 높은 함량을 나타났다. 블루베리 와인의 경우 오디 및 복분자와 달리 모두 5% 이상의 알코올 함량을 나타내긴 하였으나 원 재료인 블루베리의 높은 산도로 인하여 효모 균주 자체가 생육을 하는데는 어려움을 갖고 있으며, 이로 인하여 선별 효모의 당 소비에 의한 알코올의 생성이 저조한 것으로 사료된다.The results of analyzing the alcohol content by preparing berry wines using seven strains of BBA03, BBA19, BBA23, BA34, BBA46, BBA88, and BBA91 identified as Saccharomyces cerevisiae are shown in Table 4. Ethanol and blueberries, ethanol was not detected in the control group without inoculation of the strain into the bokbunja stock solution, and in the case of Audi wine, the commercial yeast (grain) inoculated with the control was the highest with 18.82%, and among the selected strains, the BBA23 strain The wine produced by inoculation was the highest with an alcohol content of 17.01%. In blueberry wine, 6 strains except BBA03 selected were higher than 2 commercial yeasts inoculated with control. In the case of double-molecule wine, BA34 was the highest among the selected strains including the control at 18.68%. In the case of blueberry wine, unlike Audi and bokbunja, both showed an alcohol content of 5% or more, but due to the high acidity of the raw material blueberry, the yeast strain itself has difficulty in growing, thereby reducing sugar consumption of the selected yeast. The production of alcohol by is thought to be poor.
실시예Example 5. 우레아제( 5. Urease ( UreaseUrease ) ) 생성여부 확인Confirmation of creation
세포손상을 주는 기전으로 헬리코박터 파일로리(Helicobacter pylori) 감염 시 우레아제에 의해 생성되는 암모니아(ammonia)에 의해 세포 손상이 생기고, Vac A에 의해 상피세포의 공포화가 발생하는데 호중구에서 분비된 염증매개물질과 활성 산소화물에 의해서도 세포가 손상된다. 상피세포의 손상은 세포의 위축성 변화를 일으키고 세포손상에 대한 보상기전으로 세포증식이 증가하며 활발하게 증식하는 세포는 발암물에 의하여 유전자가 손상을 받을 기회가 많아진다. 따라서 우레아제 생성 여부를 확인하기 위한 실험을 진행하였고, 측정결과 BBA19, BA34, BBA46, BBA91 균주에서 우레아제가 생성되지 않음을 확인하였다(표 5). As a mechanism of cell damage, cell infection is caused by ammonia produced by urease when Helicobacter pylori infection, and phobias of epithelial cells are caused by Vac A. Inflammatory substances secreted from neutrophils and activity Cells are also damaged by oxygenates. Damage to epithelial cells causes atrophic changes in cells, cell proliferation increases as a compensation mechanism for cell damage, and cells that actively proliferate have a greater chance of damaging genes by carcinogens. Therefore, an experiment was conducted to check whether urease was generated, and it was confirmed that urease was not generated in the BBA19, BA34, BBA46, and BBA91 strains (Table 5).
실시예Example 6. β- 6. β- 글루코시다제Glucosidase 효소활성 Enzyme activity
β-글루코시다제(β-glucosidase)는 비배당체의 형성과 이소플라본 배당체의 가수분해에 필요한 촉매작용을 한다고 알려져 있다. β-글루코시다제를 생산하는 미생물로는 아스퍼질러스 나이거(Aspergillus niger), 트라이코더마 레제이(Trichoderma reesei), 푸사리움 옥시스포룸(Fusarium oxysporum) 등의 곰팡이와 사카로마이세스 세레비지애(Saccharomyces cerevisiae), 스키조사카로마이세스 폼베(Schizosaccharoyces pombe) 등의 효모 그리고 토양세균으로 스트렙토마이세스 레티쿨리(Streptomyces reticuli), 바실러스 서틸리스(Bacillus subtilis), 바실러스 폴리믹사(Bacillus polymyxa), 바실러스 서큘란스(Bacillu circulans), 아그로박테리움 튜머파시엔스(Agrobacterium tumefaciens), 셀룰로모나스 종(Cellulomonas sp.) CS1-1 및 초고온성 고세균인 피로코커스 푸리오수스(Pyrococcus furiosus) 등 다양한 계통군에 속하는 균주들이 알려져 있고, 이들이 생산하는 β-글루코시다제에 대한 효소학적 특성과 유전자도 다수 밝혀졌다. 전통발효식품에 주로 존재하는 대두 이소플로본 배당체인 제니스틴과 다이드진의 체내 흡수를 위해 비배당체 형태로 전환하는 생물전환 공정에 활용가능성을 갖는 β-글루코시다제 활성 확인 결과 BA34 균주의 경우 β-글루코시다제의 활성이 우수한 것으로 확인되었다(표 6).β-glucosidase (β-glucosidase) is known to catalyze the formation of non-glycosides and hydrolysis of isoflavone glycosides. As a microorganism that produces β-glucosidase, Aspergillus niger , Trichoderma reesei , Fusarium oxysporum ( Fusarium) molds such as oxysporum ) and Saccharomyces cerevisiae ), Schizosaccharoyces pombe Streptomyces reticuli , Bacillus subtilis , Bacillus polymyxa , Bacillus circulatory ( Bacillu) circulans ), Agrobacterium tumefaciens ), Cellulomonas sp.CS1-1 and strains belonging to various lineages such as Pyrococcus furiosus , an ultra-high temperature bacterium, are known, and for the β-glucosidase they produce Enzymatic properties and genes have also been identified. As a result of confirming the activity of β-glucosidase having bioavailability in the bioconversion process to convert into non-glycoside form for absorption by the soybean isoflavone glycosides, genistin and didazine, which are mainly present in traditional fermented foods, β- for BA34 strain It was confirmed that the activity of glucosidase was excellent (Table 6).
실시예Example 7. 효모의 동정 및 계통수 작성 7. Identification of yeast and creation of phylogenetic tree
선별 균주 BA34의 동정을 위해 ITS1과 ITS4 프라이머를 이용해 유전자를 증폭하여 18S rRNA 유전자 염기서열을 분석하였다. 분석한 결과를 GenBank에서 BLAST 결과 사카로마이세스 세레비지애(S. cerevisiae)로 판명되었으며, 염기서열은 서열번호 1과 같다. 염기서열을 이용하여 SeqMatch program에서 상동성 높은 표준균주와 상호비교를 실시하였다. 18S rRNA 유전자 염기서열을 토대로 하여 계통수를 작성하여 계통수를 분석하였고(도 1), 최종적으로 사카로마이세스 세레비지애 BA34로 명명하였다. 최종 선별균주인 BA34는 한국미생물보존센터(KCCM, Korean Culture Center of Microorganisms)에 사카로마이세스 세레비지애 KCCM12243P로 기탁하였다. For identification of the selected strain BA34, the gene was amplified using ITS1 and ITS4 primers to analyze the 18S rRNA gene sequence. As a result of BLAST in GenBank, the analyzed result was identified as S. cerevisiae , and the nucleotide sequence is shown in SEQ ID NO: 1. In the SeqMatch program, nucleotide sequences were used to perform cross-comparison with highly homologous standard strains. Phylogenetic trees were prepared based on the 18S rRNA gene base sequence (FIG. 1), and finally designated as Saccharomyces cerevisiae BA34. The final selected strain, BA34, is Saccharomyces cerevisiae at the Korean Culture Center of Microorganisms (KCCM). Deposited with KCCM12243P.
실시예Example 8. 선별 균주의 알코올 내성, 당 내성 및 아황산 내성 8. Alcohol resistance, sugar resistance and sulfurous acid resistance of selected strains
사카로마이세스 세레비지애 균주의 종균 배양은 아로마틱 향기 성분의 생산과 아황산 및 알코올 내성의 증가로 인해 일반적으로 사용된다. 따라서, 알코올, 당, 아황산 저항성은 포도 와인의 제조시 고농도의 포도당과 알코올, 아황산이 첨가됨으로 와인 제조를 위한 효모로써는 필수적인 요소이다. 따라서, 알코올, 당, 아황산 내성은 베리류를 이용한 와인 제조를 위한 효모로써의 가능성을 확인하기 위하여 선별한 균주의 내성을 조사하였다. Saccharomyces cerevisiae strains are commonly used because of the production of aromatic scent components and increased sulfite and alcohol resistance. Therefore, alcohol, sugar, and sulfurous acid resistance are essential elements as yeast for wine production due to the addition of high concentrations of glucose, alcohol, and sulfurous acid in the production of grape wine. Therefore, the resistance of alcohol, sugar, and sulfurous acid was examined for the resistance of selected strains to confirm the possibility as yeast for wine production using berries.
BA34의 알코올 내성의 조사를 위하여 무수 에탄올을 0, 8, 14, 20%를 일반 효모 배양 배지인 YPD 액체배지에 첨가하여 건조 균체량을 조사하여 내성여부를 확인하였다. 건조 균체량은 도 2A와 같으며 8%를 첨가한 실험구에서는 대조구 (6.63 g/ℓ)에 비하여 2.78 g/ℓ로 감소하였으며, 고농도 첨가구에서는 거의 생장하지 못하였다. 이는 초기 포도당과 알코올의 농도가 높을 경우 최종 바이오매스 농도는 낮다는 선행 연구 결과와 유사한 결과를 확인하였다. 하지만 알코올 내성에 대한 다른 문헌들과 비교하여 보아도 8% 이상의 농도에서는 잘 성장하지 못하므로 다른 연구 결과들과는 큰 차이를 보이지는 않았다.To investigate the alcohol resistance of BA34, 0, 8, 14, and 20% anhydrous ethanol were added to the YPD liquid medium, which is a general yeast culture medium, and the dry cell mass was examined to confirm resistance. The amount of dried cells was as shown in Fig. 2A, and in the experimental group with 8% added, it decreased to 2.78 g / L compared to the control (6.63 g / L) and hardly grown in the high concentration added group. This confirmed results similar to those of previous studies that the final biomass concentration was low when the initial glucose and alcohol concentrations were high. However, compared to other literature on alcohol resistance, it did not show a significant difference from other research results because it did not grow well at a concentration of 8% or more.
당 내성은 도 2B와 같으며, 일반 효모 배양 배지인 YPD의 균체량 (6.04 g /L)과 비교하여 30%의 포도당을 첨가한 실험구에서 10.13 g/ℓ으로 크게 증가하였다. 앞선 Calado 등 (2003)과 Kim 등이 제시한 4% 이상의 당이 첨가되었을 경우 균체량 및 알코올 생성능이 낮다는 결과와 다른 결과를 보였다. 반면, 40%와 50%의 포도당이 첨가된 실험구에서는 9.16 g/ℓ와 8.99 g/ℓ로 감소하였으나 고농도의 포도당이 첨가된 실험구의 경우에서도 성장에는 많은 영향을 받지 않는다는 것을 확인하였다. 하지만 포도당의 첨가 비율이 증가할수록 균체 성장률이 감소한 것은 바이오매스 생산량 감소와 당의 고동도 첨가에 따른 배양 배지에서의 물 순환에 어려움으로 인한 결과 건조 균체량 또한 감소한 것으로 분석되었다.The sugar resistance was as shown in FIG. 2B, and significantly increased to 10.13 g / L in the experimental group with 30% glucose added, compared to the cell mass (6.04 g / L) of YPD, a general yeast culture medium. When more than 4% of sugars suggested by Calado et al. (2003) and Kim were added, the results showed that the cell mass and alcohol production capacity were low. On the other hand, 40% and 50% glucose was added to the experimental group decreased to 9.16 g / ℓ and 8.99 g / ℓ, but it was confirmed that even in the experimental group to which high concentration of glucose was added, it was not affected much by growth. However, as the addition rate of glucose increased, the cell growth rate decreased as a result of the difficulty in circulation of water in the culture medium due to the decrease in biomass production and the high degree of sugar addition, the dry cell mass was also decreased.
아황산은 식품 및 음료와 약품의 보존의 용도로 첨가되는 물질로써, 산화 방지 및 항균효과와 갈변효과 방지 등의 효과로 인해 이용되는 물질이다. 따라서, 와인 제조시 산화 방지와 선택적 유해 미생물 억제능을 위하여 사용이 된다. 따라서 효모는 와인제조를 위해서는 아황산 내성을 가질 필요성이 있다. 현재 국내 식품 규격상 350 ㎎/ℓ의 첨가 허용 규격에 맞추어 100, 200, 300 ppm의 아황산을 첨가하여 내성을 조사한 결과는 도 2C와 같으며, 아황산 첨가에 따라 BA34는 대조구인 6.04 g/ℓ에 비교하여 4.64 g/ℓ, 4.11 g/ℓ, 4.52 g/ℓ로 약간의 감소의 경향을 보이긴 하였으나, 큰 영향을 받지 않아 베리류 와인제조를 위한 효모로 사용이 가능함을 확인할 수 있었다. Sulfuric acid is a substance that is added for the preservation of food, beverages, and drugs, and is used because of its anti-oxidation, anti-bacterial, and browning-resistant effects. Therefore, it is used to prevent oxidation and selectively inhibit harmful microorganisms in wine production. Therefore, yeast needs to have sulfite resistance for wine production. According to the current domestic food standard, the results of investigating resistance by adding sulfuric acid of 100, 200, 300 ppm in accordance with the allowable specification of 350 mg / ℓ are as shown in FIG. 2C. In comparison, although the tendency of slight decrease was 4.64 g / ℓ, 4.11 g / ℓ, and 4.52 g / ℓ, it was confirmed that it can be used as yeast for berry wine production because it is not greatly affected.
<110> Microbial Institute for Fermentation Industry <120> Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof <130> PN18147 <160> 1 <170> KopatentIn 2.0 <210> 1 <211> 813 <212> DNA <213> Saccharomyces cerevisae <400> 1 ggaaggatca ttaaagaaat ttaataattt tgaaaatgga ttttttttgt tttggcaaga 60 gcatgagagc ttttactggg caagaagaca agagatggag agtccagccg ggcctgcgct 120 taagtgcgcg gtcttgctag gcttgtaagt ttctttcttg ctattccaaa cggtgagaga 180 tttctgtgct tttgttatag gacaattaaa accgtttcaa tacaacacac tgtggagttt 240 tcatatcttt gcaacttttt ctttgggcat tcgagcaatc ggggcccaga ggtaacaaac 300 acaaacaatt ttatttattc attaaatttt tgtcaaaaac aagaattttc gtaactggaa 360 attttaaaat attaaaaact ttcaacaacg gatctcttgg ttctcgcatc gatgaagaac 420 gcagcgaaat gcgatacgta atgtgaattg cagaattccg tgaatcatcg aatctttgaa 480 cgcacattgc gccccttggt attccagggg gcatgcctgt ttgagcgtca tttccttctc 540 aaacattctg tttggtagtg agtgatactc tttggagtta acttgaaatt gctggccttt 600 tcattggatg tttttttttc caaagagagg tttctctgcg tgcttgaggt ataatgcaag 660 tacggtcgtt ttaggtttta ccaactgcgg ctaatctttt ttatactgag cgtattggaa 720 cgttatcgat aagaagagag cgtctaggcg aacaatgttc ttaaagtttg acctcaaatc 780 aggtaggagt acccgctgaa cttaagcata tca 813 <110> Microbial Institute for Fermentation Industry <120> Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof <130> PN18147 <160> 1 <170> KopatentIn 2.0 <210> 1 <211> 813 <212> DNA <213> Saccharomyces cerevisae <400> 1 ggaaggatca ttaaagaaat ttaataattt tgaaaatgga ttttttttgt tttggcaaga 60 gcatgagagc ttttactggg caagaagaca agagatggag agtccagccg ggcctgcgct 120 taagtgcgcg gtcttgctag gcttgtaagt ttctttcttg ctattccaaa cggtgagaga 180 tttctgtgct tttgttatag gacaattaaa accgtttcaa tacaacacac tgtggagttt 240 tcatatcttt gcaacttttt ctttgggcat tcgagcaatc ggggcccaga ggtaacaaac 300 acaaacaatt ttatttattc attaaatttt tgtcaaaaac aagaattttc gtaactggaa 360 attttaaaat attaaaaact ttcaacaacg gatctcttgg ttctcgcatc gatgaagaac 420 gcagcgaaat gcgatacgta atgtgaattg cagaattccg tgaatcatcg aatctttgaa 480 cgcacattgc gccccttggt attccagggg gcatgcctgt ttgagcgtca tttccttctc 540 aaacattctg tttggtagtg agtgatactc tttggagtta acttgaaatt gctggccttt 600 tcattggatg tttttttttc caaagagagg tttctctgcg tgcttgaggt ataatgcaag 660 tacggtcgtt ttaggtttta ccaactgcgg ctaatctttt ttatactgag cgtattggaa 720 cgttatcgat aagaagagag cgtctaggcg aacaatgttc ttaaagtttg acctcaaatc 780 aggtaggagt acccgctgaa cttaagcata tca 813
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180054661A KR102088696B1 (en) | 2018-05-14 | 2018-05-14 | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180054661A KR102088696B1 (en) | 2018-05-14 | 2018-05-14 | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190130247A KR20190130247A (en) | 2019-11-22 |
KR102088696B1 true KR102088696B1 (en) | 2020-03-13 |
Family
ID=68730839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180054661A KR102088696B1 (en) | 2018-05-14 | 2018-05-14 | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102088696B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102251303B1 (en) * | 2020-11-27 | 2021-05-11 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisiae SRCM101756 strain for increasing rutin content in fermented mulberry and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101904164B1 (en) | 2018-05-04 | 2018-10-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101599269B1 (en) * | 2014-02-14 | 2016-03-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisiae BA29 strain producing alcohol and nonproducing biogenic amine isolated from Rubus coreanus fruit and uses therof |
KR101599270B1 (en) * | 2014-02-14 | 2016-03-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisiae BA33 strain producing alcohol and nonproducing biogenic amine isolated from Mulberry and uses therof |
KR101599271B1 (en) * | 2014-02-14 | 2016-03-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisiae BA42 strain producing alcohol and nonproducing biogenic amine isolated from berry and uses therof |
-
2018
- 2018-05-14 KR KR1020180054661A patent/KR102088696B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101904164B1 (en) | 2018-05-04 | 2018-10-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102251303B1 (en) * | 2020-11-27 | 2021-05-11 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisiae SRCM101756 strain for increasing rutin content in fermented mulberry and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20190130247A (en) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101904164B1 (en) | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
Brizuela et al. | Lactobacillus plantarum as a malolactic starter culture in winemaking: A new (old) player? | |
KR101618260B1 (en) | Pichia kudriavzevii n77-4 and its use | |
WO2017210815A1 (en) | Microbial strain and application thereof in production of pu'er tea | |
KR101859707B1 (en) | Process for production of distilled spirit | |
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
CN111378605B (en) | Lactobacillus plantarum for biological deacidification of high-yield volatile ester compounds and application of lactobacillus plantarum in fruit wine | |
CN109971689B (en) | Pediococcus pentosaceus ZF618 and application thereof | |
CN113564089B (en) | Lactobacillus plantarum LHP710 capable of producing gamma-aminobutyric acid and application thereof | |
CN105754887B (en) | Lactobacillus pentosus for producing gamma-aminobutyric acid and application of lactobacillus pentosus in production of Pu' er tea | |
KR20220116000A (en) | Saccharopolispora and its application in reducing biogenic amines | |
CN111961600A (en) | Solid-state fermentation aroma-producing yeast and application thereof | |
KR101422248B1 (en) | Issatchenkia orientalis ms-1 and its use | |
KR20200137232A (en) | Preparation method of kombucha using autolysate of yeast as nitrogen source | |
KR102088696B1 (en) | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
KR102088693B1 (en) | Saccharomyces cerevisae BA31 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
CN111363699B (en) | Lactobacillus plantarum with both biological amine degradation activity and biological acid reduction activity and application of lactobacillus plantarum in fruit wine | |
CN112586596A (en) | Solid state fermentation method for improving nutritive value of tea leaves | |
KR102226280B1 (en) | Saccharomyces cerevisiae FT4-2 strain producing beta-glucan isolated from blueberry and uses therof | |
KR20140057092A (en) | Pichia anomala and brewed fermented alcohol made there with | |
CN113773977B (en) | Yeast strain with low ethanol yield and high aroma yield and application thereof | |
KR101809447B1 (en) | Leuconostoc mesenteroides DRC1506 and Use thereof | |
Yao et al. | Growth capacity of Bacillus potential starter strains isolated from cocoa beans fermentation under culture stress conditions | |
CN109913379B (en) | High-esterase-activity Meiji yeast and application thereof in fermentation of mead | |
KR102226310B1 (en) | Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |